Blaize to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025
Acurx Pharmaceuticals, Inc. Announces Closing of $1.1 Million Registered Direct Offering
Cleancore solutions CEO Adams buys $1,970 in stock
Bioage Labs principal accounting officer Barton Shane buys $47,376 in common stock
Tyler Technologies executive chair Marr sells $3.71 million in stock
US FDA to hold off action on weight-loss drug copies pending court ruling
Novartis CEO believes radiopharmaceutical business will be worth $10 billion – Nikkei
Latest articles
Popular articles
Featured
Newsletter
Subscribe to get the latest news, offers and special announcements.


